Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending oral dose study of Org 201745-0 in healthy sterilized women
NL-OMON30881Active, not recruiting
- Sponsor
- Orion Corporation
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in contraception comparing Org 201745-0 single-dose escalation with Placebo (2 arms). Primary endpoints: Safety, Tolerability and 4 more. Started May 2007; status: active, not recruiting.
02
Drugs
Org 201745-0
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON30881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30881.